Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 4/20 | 0.63 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.63 |
| ▸ | PDK3 | Q15120 | 4/20 | 0.63 |
| ▸ | PDK4 | Q16654 | 4/20 | 0.63 |
| ▸ | PGR | P06401 | 3/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.52 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.52 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.52 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.47 |
| ▸ | SHBG | P04278 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8467502 | 0.86 | PGR (0.56) | PDK1PDK2PDK3PDK4PGR | |
| SCHEMBL6841786 | 0.78 | PDK1 (1.00) | PDK1PDK2PDK3PDK4PGR | |
| SCHEMBL29370141 | 0.72 | PGR (0.78) | PDK1PDK2PDK3PDK4PGR | |
| SCHEMBL8530266 | 0.72 | PGR (0.78) | PDK1PDK2PDK3PDK4PGR | |
| SCHEMBL9523036 | 0.72 | PGR (0.78) | PDK1PDK2PDK3PDK4PGR | |
| SCHEMBL3677252 | 0.71 | PGR (0.59) | PDK1PDK2PDK3PDK4PGR | |
| SCHEMBL5173779 | 0.70 | NR1I2 (0.62) | PDK1PDK2PDK3PDK4PGR | |
| SCHEMBL5173777 | 0.70 | NR1I2 (0.62) | PDK1PDK2PDK3PDK4PGR | |
| SCHEMBL5200586 | 0.69 | PDK1 (0.56) | PDK1PDK2PDK3PDK4PGR | |
| SCHEMBL9541216 | 0.69 | PDK1 (0.74) | PDK1PDK2PDK3PDK4PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040043943-A1 | Method for the management of incontinence | ALZA CORPORATION | 2004-03-04 | — | — | US | claimed |
| US-20040037881-A1 | Method for the management of incontinence | ALZA CORPORATION | 2004-02-26 | — | — | US | claimed |
| US-6262115-B1 | ADMITTING ORALLY INTO THE PATIENT A DOSAGE FORM OF OXYBUTYNIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALT, THAT IS ADMINISTERED ONCE-A-DAY AS SUSTAINED-RELEASE FORM FOR MANAGEMENT OF INCONTINENCE | ALZA COPORATION | 2001-07-17 | — | — | US | claimed |
| US-20080021102-A1 | Method for the Management of Incontinence | ALZA CORPORATION (US) | 2008-01-24 | — | — | US | disclosed |
| US-6919092-B2 | Method for the management of incontinence | ALZA CORPORATION (US) | 2005-07-19 | — | — | US | disclosed |
| US-20040043943-A1 | Method for the management of incontinence | ALZA CORPORATION | 2004-03-04 | — | — | US | disclosed |
| US-20040037881-A1 | Method for the management of incontinence | ALZA CORPORATION | 2004-02-26 | — | — | US | disclosed |
| US-6262115-B1 | ADMITTING ORALLY INTO THE PATIENT A DOSAGE FORM OF OXYBUTYNIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALT, THAT IS ADMINISTERED ONCE-A-DAY AS SUSTAINED-RELEASE FORM FOR MANAGEMENT OF INCONTINENCE | ALZA COPORATION | 2001-07-17 | — | — | US | disclosed |
| US-20010005728-A1 | Method for the management of incontinence | ALZA CORPORATION | 2001-06-28 | — | — | US | disclosed |